Implementation of manufacturing innovation for technological development of Perilis Trading ltd.

The introduction of innovative products in order to increase the overall competitiveness of the company is a systematic and consistent vision of the management. In 2018, PERILIS TRADING started production of innovative for our country washing and cleaning products with useful bacteria - probiotics. In these preparations, a combination of several types of specially selected gram-positive beneficial bacteria from the Bacillius family, called CONSORTIUM CS4, is used in the form of spores. Leaving the bottle, the disputes find the right conditions for development in the environment. To absorb them, they release enzymes that degrade the compounds, thus neutralizing them. Thus, they act as a natural biological filter, purifying the air, surfaces and objects, eliminating organic allergens, cigarette smoke smells, pets, moisture, sweat and more. Probiotic strain products are widely used, for example - hotels, restaurants, offices, schools, hospitals, SPA centers, public areas. Their natural origin helps to maintain ecological cleanliness and balance in the environment, surpassing in all safety and safety indicators flavors that are widely used in everyday life. The need for an effective process for the production of products with probiotic strains included, provoked the management to invent and implement a technological process with high production capacity, through which the company would gain a competitive advantage and use to produce products at competitive prices. In order to increase the demand and the potential for realization of the products with probiotic composition, the following innovative technological line needs to be implemented: - Line for production, filling, closing and labeling of cosmetic and cleaning probiotic products - 1 pc. The line is a process of sequentially connecting machines and systems in a fully equipped production line.

Comments
Leave a comment

Overview

Status In execution (starting date)
Start date 25 Feb, 2021
End date 25 Aug, 2022
Contract date 25 Feb, 2021
View in UMIS

Financial information

Total cost 390,200.00
Grant 351,180.00
Self finance 39,020.00
Total paid 0.00
EU participation percent 85.0%

Location